Optic Nerve Sheath Diameter and the Duration of Extracorporeal Life Support During Newborn Cardiac Surgery

Sponsor
Konya City Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05930691
Collaborator
(none)
22
1
1.2
18.1

Study Details

Study Description

Brief Summary

Mortality rates for newborns with congenital heart disease (CHD) have dramatically decreased thanks to surgical methods and medical treatment improvements. Up to 70% of patients may have post- Extracorporeal life support (ECLS) cerebral dysfunction, which can result in long-term cognitive and motor impairment, first showing as brain edema and higher intracranial pressure (ICP). Optic Nerve Sheath Diameter (ONSD) is a non-invasive method of measuring Intracranial Pressure (ICP). The Primary Aim of this study is to identify the correlation between ONSD and ECLS time in newborns who get ECLS.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Optic nerve sheath diameter measurement

Detailed Description

INTRODUCTION Mortality rates for newborns with congenital heart disease (CHD) have dramatically decreased thanks to surgical methods and medical treatment improvements. As a result, more emphasis is being put on reducing neonatal cardiac surgery morbidity.

Extracorporeal life support (ECLS) is increasingly being given to children, particularly for cardiac causes, according to the Pediatric Extracorporeal Life Support Organization Registry's global report. However, up to 70% of patients may have post-ECLS cerebral dysfunction, which can result in long-term cognitive and motor impairment, first showing as brain edema and higher intracranial pressure (ICP). In addition, pediatric patients may have trouble being diagnosed with acute elevations in IİCP since the signs and symptoms are sometimes unclear.

The gold standard for measuring intracranial pressure (ICP) still involves invasive intracranial devices. In addition, ICP monitors have the potential to cause complications, including bleeding in 1.1-5.8% of cases, malfunction, in 6.3-40% of cases, or infection in 0-15% of cases, with a noticeable higher risk of bacterial colonization after five days.

The optic nerve sheath surrounds the Optic Nerve (ON) and covers the optic subarachnoid space, which is connected to the intracranial subarachnoid space area. Changes in intracranial pressure are thus straightly transferred to the optic nerve sheath. Therefore, Optic Nerve Sheath Diameter (ONSD) is a non-invasive method of measuring Intracranial Pressure (ICP).

Longer ECLS periods and aortic cross-clamp times have been linked to more frequent CT detection of cerebral edema, according to prior investigationsAccording to prior investigations, long ECLS periods, and aortic cross-clamp times have been linked to more frequent CT (computer tomography) detection of cerebral edema. However, there is currently no information on the relationship between these time points and the ONSD determined by ultrasound.

The Primary Aim of this study was to identify the correlation between ONSD and ECLS time in newborns who get ECLS. Specifically, we tested the primary hypothesis that more ECLS time means more ONSD valuable over the perioperative period. Our secondary aim was to investigate the relationship between ONSD and aortic cross-clamp time and operation time and also, operation time and preoperative and intraoperative perioperative ONSD variation for the ECLS period.

Study Design

Study Type:
Observational
Actual Enrollment :
22 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Evaluation of the Association Between the Optic Nerve Sheath Diameter and Extracorporeal Life Support Time During Cardiac Surgery in Newborn
Actual Study Start Date :
May 15, 2023
Actual Primary Completion Date :
Jun 13, 2023
Actual Study Completion Date :
Jun 21, 2023

Outcome Measures

Primary Outcome Measures

  1. Correlation between optic nerve sheath diameter and extra corperal support life time. [Basal; the 15. minutes after aort cross clamp; the time of removing cross clamp; End of the operation.]

    The Primary outcome of this study will be identifing ONSD in ECLS time in newborns.

Secondary Outcome Measures

  1. Staticticaly meaningful between Cross clamp time and optic nerve sheath diameter [Basal; the 15. minutes after aort cross clamp; the time of removing cross clamp; End of the operation.]

    Our secondary outcome will be ONSD in aortic cross-clamp time.

  2. Staticticaly meaningful between operation time and optic nerve sheath diameter [Basal; the 15. minutes after aort cross clamp; the time of removing cross clamp; End of the operation.]

    Our secondary outcome will be ONSD in operation time.

  3. Perioperative ONSD variation for the ECLS period. [Basal; the 15. minutes after aort cross clamp; the time of removing cross clamp; End of the operation.]

    Our secondary outcome will be ONSD variation for the ECLS period.

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Day to 28 Days
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • ASA III or IV status newborn;

  • Have surgery for transposition of great arteries (TGA).

Exclusion Criteria:
  • All off-pump cardiac surgery;

  • Recent history of cerebrovascular accident or intracranial hypertension due to any cause;

  • History of increased ICP;

  • Ophthalmological diseases capable of affecting optic nerve diameters.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Konya City Hospital Konya Karatay Turkey 42020

Sponsors and Collaborators

  • Konya City Hospital

Investigators

  • Principal Investigator: Aydın Mermer, MD, Konya City Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Aydın Mermer, Vice Director, Head of Anesthesiology, Principal Investigator, Clinical Speicialist, Konya City Hospital
ClinicalTrials.gov Identifier:
NCT05930691
Other Study ID Numbers:
  • 2023/4253
First Posted:
Jul 5, 2023
Last Update Posted:
Jul 6, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Aydın Mermer, Vice Director, Head of Anesthesiology, Principal Investigator, Clinical Speicialist, Konya City Hospital

Study Results

No Results Posted as of Jul 6, 2023